Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Akin

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
The American Journal of Surgical Pathology|March 13, 2014
A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patientsLeona A Doyle, Golrokh J Sepehr, Matthew J Hamilton, et al.
Blood|July 20, 2007
Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxisCem Akin, Linda M Scott, Can N Kocabas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2026
Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM)James C Marcus, Cem Akin, Jenna Zhang, et al.
Archives of Dermatology|June 12, 2002
Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of diseaseKnut Brockow, Linda M Scott, Alexandra S Worobec, et al.
Leukemia & Lymphoma|September 4, 2008
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cellsOzden Ozer, Yi D Zhao, Kelly R Ostler, et al.
Annual Review of Pathology|October 21, 2022
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and TherapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Expert Review of Hematology|August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematologyPeter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
The Journal of Allergy and Clinical Immunology|April 25, 2021
Prevalence of mastocytosis and Hymenoptera venom allergy in the United StatesCharles F Schuler, Sofija Volertas, Dilawar Khokhar, et al.
Blood|February 28, 2002
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutationsYongsheng Ma, Shan Zeng, Dean D Metcalfe, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
The American Journal of Surgical Pathology|March 13, 2014
A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patientsLeona A Doyle, Golrokh J Sepehr, Matthew J Hamilton, et al.
Blood|July 20, 2007
Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxisCem Akin, Linda M Scott, Can N Kocabas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2026
Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM)James C Marcus, Cem Akin, Jenna Zhang, et al.
Archives of Dermatology|June 12, 2002
Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of diseaseKnut Brockow, Linda M Scott, Alexandra S Worobec, et al.
Leukemia & Lymphoma|September 4, 2008
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cellsOzden Ozer, Yi D Zhao, Kelly R Ostler, et al.
Annual Review of Pathology|October 21, 2022
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and TherapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Expert Review of Hematology|August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematologyPeter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
The Journal of Allergy and Clinical Immunology|April 25, 2021
Prevalence of mastocytosis and Hymenoptera venom allergy in the United StatesCharles F Schuler, Sofija Volertas, Dilawar Khokhar, et al.
Blood|February 28, 2002
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutationsYongsheng Ma, Shan Zeng, Dean D Metcalfe, et al.
Pageof 21